Miller Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$174K Sell
480
-50
-9% -$17.1K 0.07% 123
2026
Q1
$186K Hold
530
0.09% 119
2025
Q4
$173K Buy
+530
New +$168K 0.09% 120

Other funds holding AMGN

Miller Capital Partners's AMGN Position: Q2 2026 in Review

Miller Capital Partners reduced its Amgen (AMGN) stake by 9.4% in Q2 2026, selling an estimated $17.1K and leaving 480 shares worth $174K. The position accounts for 0.07% of the portfolio, ranked #123.

Miller Capital Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $186K in Q1 2026. 3,136 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Miller Capital Partners held 480 shares of Amgen worth $174K as of Q2 2026.
  • Miller Capital Partners sold 50 Amgen shares in Q2 2026, an estimated $17.1K.
  • Amgen made up 0.07% of Miller Capital Partners's portfolio in Q2 2026, its #123 holding.
  • Miller Capital Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Miller Capital Partners's Amgen position peaked at $186K in Q1 2026.
  • 3,136 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Miller Capital Partners's 13F filing for Q2 2026, filed 12 Aug 2026.